SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 51 filers reported holding SIERRA ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $17,000 | -32.0% | 52,442 | -18.7% | 0.00% | -33.3% |
Q3 2019 | $25,000 | -83.6% | 64,500 | -76.3% | 0.00% | -72.7% |
Q2 2019 | $152,000 | -77.6% | 271,900 | -31.5% | 0.01% | -64.5% |
Q1 2019 | $678,000 | +23.9% | 396,800 | -4.3% | 0.03% | -18.4% |
Q4 2018 | $547,000 | -17.2% | 414,600 | +6.5% | 0.04% | 0.0% |
Q3 2018 | $661,000 | -32.5% | 389,300 | +17.6% | 0.04% | -33.3% |
Q2 2018 | $979,000 | +94.2% | 330,900 | +35.7% | 0.06% | +78.1% |
Q1 2018 | $504,000 | +72.6% | 243,800 | +29.2% | 0.03% | +100.0% |
Q3 2017 | $292,000 | – | 188,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
PA Capital LLC | 138,752 | $183,000 | 0.19% |
683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |